HIT Consultant July 8, 2025
What You Should Know:
– Plexāā, a pioneering UK-based MedTech startup behind the award-winning BLOOM⁴³ medical device for breast surgery closes $4.5M funding extension round led by TCP Health Ventures. The extension round includes both existing and new investors, including TCP. Further investment comprises over $1.6M in i4i grant funding from the National Institute for Health and Care Research (NIHR), and $1.3M from Thena Capital, a London-based VC firm backed by the British Business Bank and focused on digital health and fast-tracked Medtech.
– The strategic capital infusion will support the imminent U.S. launch of BLOOM⁴³, lay the groundwork for future innovations, and strengthen the company’s position ahead of its planned Series A fundraising round.
Breast Cancer Surgical Readiness...
Today's Sponsors
Today's Sponsor